Homburger advised BioVersys, a clinical-stage biopharmaceutical company domiciled in Basel, on all aspects of its Initial Public Offering (IPO). The Initial Public Offer The IPO was launched on SIX Swiss Exchange, comprising a primary
Tags :Hombuger
Homburger advised Aktiengesellschaft für die Neue Zürcher Zeitung (NZZ) on the acquisition of a 25%-stake in APG SGA (APG|SGA) from the two anchor shareholders JCDecaux, advised by Bär & Karrer, and
The number of deals of at least Usd 10 billion in Europe hit the lowest number since 2009, but two out the top five major deal are in Switzerland.
